CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA-based algorithms across cancer types. Clinical care for cancer patients is hindered by insufficient biomarkers that fail to accurately predict patient response to treatment.

VANCOUVER, British Columbia & DALLAS–(BUSINESS WIRE)–Alpha Cognition, Inc. (Nasdaq: ACOG) (“ACI” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, and China Medical System Holdings Limited (CMS) (867.HK), a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability in the People’s Republic of China, today announced an exclusive licensing agreement for the

BOSTON–(BUSINESS WIRE)– #CRO–Ora announces appointment of Cindy Markham as Chief Commercial Officer

ONTARIO, Calif.–(BUSINESS WIRE)–The Prime Healthcare Foundation and the Central Maine Healthcare (CMH) Board of Directors announced they have reached an agreement for Prime Healthcare Foundation to become the sole corporate member and parent company of Central Maine Healthcare. The agreement includes the following facilities: Central Maine Medical Center, Bridgton Hospital, Rumford Hospital, Rumford Community Home, Bolster Heights, Maine College of Health Professions, CMH Cancer Care Center,

CAMBRIDGE, Mass. & SINGAPORE–(BUSINESS WIRE)–Sunbird Bio, a biotechnology company developing proprietary blood-based technologies to improve diagnosis and treatment of neurological disorders and early-stage cancer, today announced the appointment of Richard Batrla, M.D., Ph.D., MBA as chief medical officer. “There couldn’t be a better time to welcome Richard to the team as we embark on a new year and anticipate several exciting milestones ahead,” said John McDonough, executive chairman and CE

STAMFORD, Conn.–(BUSINESS WIRE)–GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through understanding gene-disease relationships, contributing to more than 85 peer-reviewed publications in 2024. These contributions, added to GeneDx’s years of dedicated research efforts, influenced the broadening of phenotypes, the discovery of new disease mechanisms and new modes of inheritance, and ulti

HOUSTON & CHICAGO–(BUSINESS WIRE)–CTMC, a joint venture between MD Anderson Cancer Center and Resilience, has entered a partnership with Syenex to advance the scalability and efficiency of engineered T cell therapies. Through this collaboration, CTMC will gain access to Syenex’s bioengineering systems, which provide a significant improvement in gene delivery efficiency and engineering timelines. Jason Bock, CEO of CTMC, stated, “Our mission is to accelerate the delivery of transformative cell

BEIJING & ALAMEDA, Calif. & TAIPEI–(BUSINESS WIRE)–Biocytogen (HKEX: 02315) en Acepodia (6976:TT) hebben vandaag een baanbrekend strategisch partnerschap aangekondigd om gezamenlijk een programma voor dual-payload bispecifieke antilichaam-geneesmiddelconjugaten (BsAD2C) te beoordelen. Deze samenwerking combineert het RenLite®-platform van Biocytogen met de Antibody-Dual-Drugs Conjugation (AD2C)-technologie van Acepodia om enkele van de moeilijkste uitdagingen in de oncologie aan te pakken: tu

ST. LOUIS & HERCULES, Calif.–(BUSINESS WIRE)–Geneoscopy raises $105 million in Series C funding round, led by Bio-Rad Laboratories

COLUMBIA, Md.–(BUSINESS WIRE)–Propelled by historic expansion of its reach across diverse systems and state lines, CRISP Shared Services (CSS) today announced significant progress throughout 2024 toward its mission of providing localized and impactful health infrastructure and data exchange technology across the United States. CSS continued its impactful work with CRISP, Maryland’s state-designated health information exchange (HIE) and Health Data Utility (HDU); CRISP DC, serving the District